This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cold-EEZEA® Cold Remedy Supports The City Harvest Daily News Readers Care To Feed The Hungry Canned Food Drive (DNRC) For The Second Consecutive Year

DOYLESTOWN, Pa., Dec. 11, 2013 /PRNewswire/ -- ProPhase Labs, Inc. (NASDAQ: PRPH), makers of Cold-EEZE ® Cold Remedy and a leader in over-the-counter (OTC) natural cold remedies, has announced that for the second consecutive year it will support The Daily News Readers Care to Feed the Hungry Canned Food Drive (DNRC), a thirty-year tradition of collecting non-perishable food donations throughout New York City. This year, Cold-EEZE ® Cold Remedy will bring celebrity guest Jenny McCarthy to assist in collecting much needed food items at the event taking place on Thursday, December 12, 2013 from 2:00 pm4:00 pm EST at Engine 8, Ladder 2, Battalion 8 Firehouse located at 165 East 51 st Street (between 3 rd Avenue and Lexington Avenue).

City Harvest is the world's first food rescue organization, dedicated to helping feed the more than one million residents facing hunger each year. Last year's drive collected over one million pounds of food, and this year City Harvest hopes to collect over one million pounds of food.

"Last year's food drive was such a success, and we are thrilled to once again partner with The Daily News and City Harvest for another great event this year; especially with Jenny McCarthy," said Ted Karkus, Chief Executive Officer of ProPhase Labs. "Following Hurricane Sandy and other tragedies across the country, it is important to take part in such a life-changing initiative and we look forward to partnering again for years to come."

"For more than 30 years, City Harvest has been working with The Daily News to achieve our mission in keeping food pantries and soup kitchens stocked across the city," said Rebecca Fontes, Associate Director of Corporate Partnerships for City Harvest. "We appreciate Cold-EEZE Cold Remedy's ongoing support and are delighted that Jenny McCarthy will be on hand at this food drive event to raise awareness about hunger in New York City and help collect much needed food for our neighbors in need."  

Jenny McCarthy, American model, comedic actress and the host of ABC's hit daytime talk show, The View, will assist in the food drive presented by the New York Daily News, City Harvest and Cold-EEZE ® Cold Remedy, which is hosted by FDNY. Additionally, those who attend and donate canned goods during the event will be given the opportunity to meet, take pictures with and receive autographs from Jenny McCarthy.

About ProPhase Labs and Cold-EEZE ® Cold Remedy

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE ® family of lozenges clinically proven to significantly reduce the duration of the common cold. Cold-EEZE ® customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE ® lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion").  Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds.  Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels.  For more information visit us at www.ProPhaseLabs.com.

Cold-EEZE ® Cold Remedy is the #1 pharmacist-recommended cold remedy and is clinically proven to reduce the duration of the common cold by nearly half. Cold-EEZE Cold Remedy recently introduced its newest QuickMelts ® formula, Cold-EEZE ® Cold Remedy Plus Natural Immune Support, which is formulated with zinc gluconate, rose hips and Echinacea to not only shorten the duration of the cold, but to keep you immune system strong and healthy, naturally.  Cold-EEZE ® Cold Remedy is also available in tasty Lozenges, a convenient Oral Spray and a quick dissolving, Daytime/Nighttime QuickMelts ®. Cold-EEZE ® Cold Remedy is available in the cold remedies aisle at over 40,000 fine retail locations.  To find a retailer or buy online please visit www.coldeeze.com.

About City Harvest

Now serving New York City for more than 30 years, City Harvest ( www.cityharvest.org) is the world's first food rescue organization, dedicated to feeding the city's hungry men, women, and children. This year, City Harvest will collect 46 million pounds of excess food from all segments of the food industry, including restaurants, grocers, corporate cafeterias, manufacturers, and farms. This food is then delivered free of charge to more than 500 community food programs throughout New York City by a fleet of trucks and bikes. City Harvest helps feed the more than one million New Yorkers that face hunger each year.

SOURCE ProPhase Labs, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,025.65 -13.84 -0.08%
S&P 500 1,992.12 -0.25 -0.01%
NASDAQ 4,545.4920 +13.3880 0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs